Regeneron Pharmaceuticals
REGN
$822.96
Share price
-1.39%
Change (1 day)
18.96%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Net assets
Net assets on the balance sheet as of June 2023 : $24.01 B
According to Regeneron Pharmaceuticals's latest financial reports the company has $24.01 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Regeneron Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $22.66 B | 20.75% |
| 2021-12-31 | $18.76 B | 70.23% |
| 2020-12-31 | $11.02 B | -0.58% |
| 2019-12-31 | $11.08 B | 26.63% |
| 2018-12-31 | $8.75 B | 42.53% |
| 2017-12-31 | $6.14 B | 38.09% |
| 2016-12-31 | $4.44 B | 21.74% |
| 2015-12-31 | $3.65 B | 43.76% |
| 2014-12-31 | $2.54 B | 30.24% |
| 2013-12-31 | $1.95 B | 56.74% |
| 2012-12-31 | $1.24 B | 156.39% |
| 2011-12-31 | $0.48 B | -7.97% |
| 2010-12-31 | $0.52 B | 33.03% |
| 2009-12-31 | $0.39 B | -5.27% |
| 2008-12-31 | $0.41 B | -9% |
| 2007-12-31 | $0.46 B | 112.47% |
| 2006-12-31 | $0.21 B | 90.02% |
| 2005-12-31 | $0.11 B | -37.55% |
| 2004-12-31 | $0.18 B | 32.62% |
| 2003-12-31 | $0.13 B | -5.71% |
| 2002-12-31 | $0.14 B | -45.19% |
| 2001-12-31 | $0.26 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.86 B | 195.07% | 🇺🇸 USA |
 Novartis NVS | $51.93 B | 116.22% | 🇨🇭 Switzerland |
 Amgen AMGN | $6.78 B | -71.77% | 🇺🇸 USA |
 Sanofi SNY | $79.27 B | 230.08% | 🇫🇷 France |
 Biogen BIIB | $14.46 B | -39.79% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.41 B | -101.70% | 🇺🇸 USA |